Passage BIO, Inc. Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Passage BIO, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • Passage BIO, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$20.7M, a 27.8% increase year-over-year.
  • Passage BIO, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$74.6M, a 36.9% increase year-over-year.
  • Passage BIO, Inc. annual Operating Income (Loss) for 2023 was -$108M, a 21.7% increase from 2022.
  • Passage BIO, Inc. annual Operating Income (Loss) for 2022 was -$138M, a 25.5% increase from 2021.
  • Passage BIO, Inc. annual Operating Income (Loss) for 2021 was -$186M, a 64.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$108M +$30M +21.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-04
2022 -$138M +$47.3M +25.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-04
2021 -$186M -$72.8M -64.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-06
2020 -$113M -$75.7M -204% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
2019 -$37.2M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.